Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.90
HUM's Cash-to-Debt is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. HUM: 0.90 )
Ranked among companies with meaningful Cash-to-Debt only.
HUM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.38  Med: 0.79 Max: N/A
Current: 0.9
Equity-to-Asset 0.42
HUM's Equity-to-Asset is ranked higher than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. HUM: 0.42 )
Ranked among companies with meaningful Equity-to-Asset only.
HUM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.35 Max: 0.46
Current: 0.42
0.26
0.46
Interest Coverage 8.21
HUM's Interest Coverage is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.87 vs. HUM: 8.21 )
Ranked among companies with meaningful Interest Coverage only.
HUM' s Interest Coverage Range Over the Past 10 Years
Min: 8.21  Med: 14.43 Max: 20.5
Current: 8.21
8.21
20.5
Beneish M-Score: -2.62
WACC vs ROIC
8.32%
15.21%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 2.85
HUM's Operating Margin % is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.72 vs. HUM: 2.85 )
Ranked among companies with meaningful Operating Margin % only.
HUM' s Operating Margin % Range Over the Past 10 Years
Min: 2.85  Med: 4.77 Max: 6.07
Current: 2.85
2.85
6.07
Net Margin % 1.09
HUM's Net Margin % is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.45 vs. HUM: 1.09 )
Ranked among companies with meaningful Net Margin % only.
HUM' s Net Margin % Range Over the Past 10 Years
Min: 1.09  Med: 3.05 Max: 3.85
Current: 1.09
1.09
3.85
ROE % 5.53
HUM's ROE % is ranked lower than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.97 vs. HUM: 5.53 )
Ranked among companies with meaningful ROE % only.
HUM' s ROE % Range Over the Past 10 Years
Min: 5.53  Med: 14.85 Max: 23.54
Current: 5.53
5.53
23.54
ROA % 2.22
HUM's ROA % is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.87 vs. HUM: 2.22 )
Ranked among companies with meaningful ROA % only.
HUM' s ROA % Range Over the Past 10 Years
Min: 2.22  Med: 6.27 Max: 8.39
Current: 2.22
2.22
8.39
3-Year Revenue Growth Rate 11.60
HUM's 3-Year Revenue Growth Rate is ranked higher than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. HUM: 11.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HUM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 1.1  Med: 9.9 Max: 25.1
Current: 11.6
1.1
25.1
3-Year EBITDA Growth Rate -2.20
HUM's 3-Year EBITDA Growth Rate is ranked lower than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.40 vs. HUM: -2.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HUM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9.5  Med: 13.4 Max: 38.5
Current: -2.2
-9.5
38.5
3-Year EPS without NRI Growth Rate -19.30
HUM's 3-Year EPS without NRI Growth Rate is ranked lower than
84% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. HUM: -19.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HUM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -19.9  Med: 18.3 Max: 41.9
Current: -19.3
-19.9
41.9
GuruFocus has detected 7 Warning Signs with Humana Inc $HUM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HUM's 10-Y Financials

Financials (Next Earnings Date: 2017-05-04)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

HUM Guru Trades in Q1 2016

George Soros 78,763 sh (New)
Steven Cohen 36,400 sh (New)
Jim Simons 446,000 sh (+246.27%)
Pioneer Investments 557,105 sh (+74.30%)
Mario Gabelli 16,743 sh (+74.04%)
David Einhorn 384,300 sh (+6.75%)
Eric Mindich Sold Out
Louis Moore Bacon Sold Out
HOTCHKIS & WILEY 972,785 sh (-1.45%)
Larry Robbins 6,424,777 sh (-22.13%)
Jeremy Grantham 743,379 sh (-34.14%)
Joel Greenblatt 3,382 sh (-50.91%)
Andreas Halvorsen 1,228,373 sh (-71.64%)
» More
Q2 2016

HUM Guru Trades in Q2 2016

Mario Gabelli 27,070 sh (+61.68%)
Jim Simons 706,800 sh (+58.48%)
Larry Robbins 8,668,249 sh (+34.92%)
Joel Greenblatt 3,699 sh (+9.37%)
Pioneer Investments 586,827 sh (+5.34%)
Jeremy Grantham 125,900 sh (unchged)
David Einhorn 384,300 sh (unchged)
Steven Cohen Sold Out
HOTCHKIS & WILEY 964,959 sh (-0.80%)
Jeremy Grantham 655,782 sh (-11.78%)
Andreas Halvorsen 811,824 sh (-33.91%)
George Soros 37,833 sh (-51.97%)
» More
Q3 2016

HUM Guru Trades in Q3 2016

Diamond Hill Capital 228,660 sh (New)
Daniel Loeb 1,400,000 sh (New)
Paul Tudor Jones 103,861 sh (New)
Steven Cohen 32,700 sh (New)
John Paulson 79,500 sh (New)
Joel Greenblatt 10,396 sh (+181.05%)
Jim Simons 913,704 sh (+29.27%)
Larry Robbins 9,529,175 sh (+9.93%)
Jeremy Grantham 343,000 sh (unchged)
George Soros 82,700 sh (unchged)
David Einhorn Sold Out
George Soros Sold Out
Mario Gabelli 26,945 sh (-0.46%)
Jeremy Grantham 649,537 sh (-0.95%)
Pioneer Investments 550,039 sh (-6.27%)
Andreas Halvorsen 640,646 sh (-21.09%)
HOTCHKIS & WILEY 527,545 sh (-45.33%)
» More
Q4 2016

HUM Guru Trades in Q4 2016

Daniel Loeb 2,400,000 sh (+71.43%)
Jim Simons 1,460,300 sh (+59.82%)
Joel Greenblatt 16,241 sh (+56.22%)
Andreas Halvorsen 737,962 sh (+15.19%)
Jeremy Grantham 343,000 sh (unchged)
Diamond Hill Capital Sold Out
HOTCHKIS & WILEY Sold Out
John Paulson Sold Out
Jeremy Grantham 563,314 sh (-13.27%)
Pioneer Investments 454,560 sh (-17.36%)
Steven Cohen 25,700 sh (-21.41%)
Mario Gabelli 20,183 sh (-25.10%)
Larry Robbins 6,313,790 sh (-33.74%)
Paul Tudor Jones 3,300 sh (-96.82%)
» More
» Details

Insider Trades

Latest Guru Trades with HUM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621610    SIC: 6324
Compare:NYSE:CI, NAS:ESRX, NYSE:AET, NYSE:ANTX, NYSE:CNC, NYSE:WCG, NYSE:MOH, OTCPK:ODPVY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, NAS:CNXR, OTCPK:OPRX, OTCPK:WCUI, NYSE:CVS, NYSE:UNH » details
Traded in other countries:HUM.Germany,
Humana Inc is a health care company that offers a insurance products and health and wellness services. Its segments include Retail, Employer Group, and Healthcare Services.

Humana is one of the largest and best-known providers of Medicare Advantage plans in the U.S. The firm specializes in providing government-sponsored plans, with close to three fourths of its membership tied to Medicare, Medicaid, or some other form of government healthcare program. Humana is also building out an extensive provider network in key geographic areas in order to control the use and cost of healthcare services. These network and the firm's brand name will also make it a major player in the nascent public exchange market.

Top Ranked Articles about Humana Inc

Trump's New Health Care Frontier Will reform have investors looking toward telemedicine?
A Donald Trump presidency has many more eyes focused on health care and the adjustment in health care reform that has been frequently discussed by the president. For investors, this tumultuous time could actually be opening up much greater opportunities not only in the health care sector but also the medical technology and telemedicine industries. Read more...

Ratios

vs
industry
vs
history
PE Ratio 53.01
HUM's PE Ratio is ranked lower than
100% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.66 vs. HUM: 53.01 )
Ranked among companies with meaningful PE Ratio only.
HUM' s PE Ratio Range Over the Past 10 Years
Min: 4.26  Med: 11.16 Max: 55.98
Current: 53.01
4.26
55.98
Forward PE Ratio 19.27
HUM's Forward PE Ratio is ranked lower than
90% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.51 vs. HUM: 19.27 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 53.01
HUM's PE Ratio without NRI is ranked lower than
100% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.10 vs. HUM: 53.01 )
Ranked among companies with meaningful PE Ratio without NRI only.
HUM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.26  Med: 11.16 Max: 55.98
Current: 53.01
4.26
55.98
Price-to-Owner-Earnings 23.78
HUM's Price-to-Owner-Earnings is ranked lower than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.64 vs. HUM: 23.78 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HUM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.73  Med: 7.53 Max: 76.26
Current: 23.78
2.73
76.26
PB Ratio 2.90
HUM's PB Ratio is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.52 vs. HUM: 2.90 )
Ranked among companies with meaningful PB Ratio only.
HUM' s PB Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.81 Max: 3.82
Current: 2.9
0.71
3.82
PS Ratio 0.57
HUM's PS Ratio is ranked lower than
52% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.60 vs. HUM: 0.57 )
Ranked among companies with meaningful PS Ratio only.
HUM' s PS Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.39 Max: 0.66
Current: 0.57
0.11
0.66
Price-to-Free-Cash-Flow 22.19
HUM's Price-to-Free-Cash-Flow is ranked lower than
84% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.97 vs. HUM: 22.19 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HUM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.75  Med: 7.3 Max: 674.15
Current: 22.19
2.75
674.15
Price-to-Operating-Cash-Flow 16.15
HUM's Price-to-Operating-Cash-Flow is ranked lower than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.04 vs. HUM: 16.15 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HUM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.49  Med: 6.2 Max: 53.29
Current: 16.15
2.49
53.29
EV-to-EBIT 13.06
HUM's EV-to-EBIT is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.01 vs. HUM: 13.06 )
Ranked among companies with meaningful EV-to-EBIT only.
HUM' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.7  Med: 3.6 Max: 14.9
Current: 13.06
-0.7
14.9
EV-to-EBITDA 10.31
HUM's EV-to-EBITDA is ranked lower than
55% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.47 vs. HUM: 10.31 )
Ranked among companies with meaningful EV-to-EBITDA only.
HUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.6  Med: 3.1 Max: 11.7
Current: 10.31
-0.6
11.7
PEG Ratio 23.04
HUM's PEG Ratio is ranked lower than
100% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.93 vs. HUM: 23.04 )
Ranked among companies with meaningful PEG Ratio only.
HUM' s PEG Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.63 Max: 23.04
Current: 23.04
0.15
23.04
Shiller PE Ratio 30.10
HUM's Shiller PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.26 vs. HUM: 30.10 )
Ranked among companies with meaningful Shiller PE Ratio only.
HUM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.68  Med: 21.04 Max: 63.04
Current: 30.1
10.68
63.04

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.56
HUM's Dividend Yield % is ranked lower than
92% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.47 vs. HUM: 0.56 )
Ranked among companies with meaningful Dividend Yield % only.
HUM' s Dividend Yield % Range Over the Past 10 Years
Min: 0.3  Med: 0.81 Max: 1.61
Current: 0.56
0.3
1.61
Dividend Payout Ratio 0.21
HUM's Dividend Payout Ratio is ranked higher than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. HUM: 0.21 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HUM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09  Med: 0.14 Max: 0.21
Current: 0.21
0.09
0.21
3-Year Dividend Growth Rate -6.70
HUM's 3-Year Dividend Growth Rate is ranked lower than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. HUM: -6.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
HUM' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 14
Current: -6.7
0
14
Forward Dividend Yield % 0.77
HUM's Forward Dividend Yield % is ranked lower than
89% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.47 vs. HUM: 0.77 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.64
HUM's 5-Year Yield-on-Cost % is ranked lower than
88% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.32 vs. HUM: 0.64 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HUM' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.35  Med: 0.95 Max: 1.88
Current: 0.64
0.35
1.88
3-Year Average Share Buyback Ratio 1.00
HUM's 3-Year Average Share Buyback Ratio is ranked higher than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. HUM: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HUM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2  Med: 0.9 Max: 3
Current: 1
-2
3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 4.34
HUM's Price-to-Tangible-Book is ranked higher than
50% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.58 vs. HUM: 4.34 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HUM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.32  Med: 3.3 Max: 12.29
Current: 4.34
1.32
12.29
Price-to-Intrinsic-Value-Projected-FCF 1.35
HUM's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.17 vs. HUM: 1.35 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HUM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.41  Med: 0.81 Max: 2.09
Current: 1.35
0.41
2.09
Price-to-Intrinsic-Value-DCF (Earnings Based) 4.65
HUM's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
100% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.44 vs. HUM: 4.65 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.47
HUM's Price-to-Median-PS-Value is ranked lower than
93% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.14 vs. HUM: 1.47 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HUM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.38  Med: 1.02 Max: 2.5
Current: 1.47
0.38
2.5
Price-to-Graham-Number 3.13
HUM's Price-to-Graham-Number is ranked lower than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.70 vs. HUM: 3.13 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HUM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.79  Med: 1.7 Max: 3.29
Current: 3.13
0.79
3.29
Earnings Yield (Greenblatt) % 7.66
HUM's Earnings Yield (Greenblatt) % is ranked higher than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.13 vs. HUM: 7.66 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HUM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 6.7  Med: 27.9 Max: 4111
Current: 7.66
6.7
4111
Forward Rate of Return (Yacktman) % 7.08
HUM's Forward Rate of Return (Yacktman) % is ranked lower than
93% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.62 vs. HUM: 7.08 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HUM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 7  Med: 27.2 Max: 51.4
Current: 7.08
7
51.4

More Statistics

Revenue (TTM) (Mil) $54,379
EPS (TTM) $ 3.91
Beta0.91
Short Percentage of Float4.40%
52-Week Range $150.00 - 220.49
Shares Outstanding (Mil)144.28

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 55,334 55,778 60,007
EPS ($) 10.66 12.00 13.50
EPS without NRI ($) 10.66 12.00 13.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
42.70%
Dividends per Share ($) 1.37 1.60 1.60
» More Articles for HUM

Headlines

Articles On GuruFocus.com
Trump's New Health Care Frontier Mar 14 2017 
Daniel Loeb Buys JPMorgan, Time Warner, Bank of America Mar 07 2017 
Insiders Roundup: The Week's Largest Buys and Sales Feb 24 2017 
Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem? Feb 22 2017 
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Jan 25 2017 
5 Stock Losers in ‘Trump Bump’ Jan 05 2017 
Hotchkis & Wiley Trims Corning, Microsoft, Exits HP Dec 05 2016 
Aetna the Undaunted Insurer Oct 31 2016 
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Aug 16 2016 
Cigna Is An Excellent Prospect, Regardless of Anthem Deal Jul 17 2016 

More From Other Websites
Why Investors Are Piling into the Largest U.S. Health Insurer Mar 24 2017
House Reps. Are Predicting Health Care Bill Vote Won't Happen Mar 24 2017
Today's charts: Investors track health care stocks ahead of vote on new bill Mar 24 2017
Healthcare scramble writes new chapter in Trump's 'Art of the Deal' Mar 24 2017
White House, House Leaders Put It All on Table For Healthcare Reform Mar 23 2017
Humana announces progress on massive population health project Mar 23 2017
Humana places near top in national customer experience survey Mar 22 2017
Humana 2020 Bold Goal Progress Report: More Healthy Days Achieved, New Programs and Communities... Mar 22 2017
Feds probe Humana on false claims to Medicare Mar 22 2017
Health care stocks under GOP plan Mar 22 2017
ACA Repeal Faces Dire Prognosis Mar 21 2017
Humana, Continucare Team with Feeding South Florida to Address High Food Insecurity Mar 21 2017
Humana Poised to Grow on Government Business, Strong Capital Mar 21 2017
Humana Inc. to Present at Oppenheimer’s 27th Annual Healthcare Conference Mar 20 2017
U.S. Republicans working on Medicaid, tax credit changes-Ryan Mar 19 2017
Obamacare Repeal to Cut Deficit, but Greatly Expand Ranks of Uninsured Mar 18 2017
U.S. investigates four insurers over Medicare payments Mar 17 2017
U.S. probing insurers beyond UnitedHealth over Medicare charges Mar 17 2017
Why Improving Population Health Makes Financial Sense Mar 17 2017
HUMANA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Mar 16 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)